Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02588352 · ClinicalTrials.gov registry record · NA
Evaluation of Salt Sensitivity in Young Adults
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02588352 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT02588352, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The current prospective cross-sectional pilot study is proposed to determine a set of characteristic factors associated with salt sensitivity in young adults by measuring blood pressure, serum aldosterone levels, urine analysis, arterial pulse wave velocity and central arterial pressure in response to short term increases in salt intake.
Interventions
- DIETARY_SUPPLEMENT Salt tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02588352
The ClinicalTrials.gov registry entry for NCT02588352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Salt tablet is the first listed.
NCT02588352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02588352 about?
NCT02588352 is a clinical study titled "Evaluation of Salt Sensitivity in Young Adults". The current prospective cross-sectional pilot study is proposed to determine a set of characteristic factors associated with salt sensitivity in young adults by measuring blood pressure, serum aldosterone levels, urine analysis, arterial pulse wave velocity and central arterial pressure in response ...
What is the current status of trial NCT02588352?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-05. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02588352?
The interventions under investigation include: Salt tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02588352?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.